Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species.
Di Luigi L, Duranti G, Antonioni A, Sgrò P, Ceci R, Crescioli C, Sabatini S, Lenzi A, Caporossi D, Del Galdo F, Dimauro I, Antinozzi C. Di Luigi L, et al. Among authors: sgro p. Antioxidants (Basel). 2020 Aug 25;9(9):786. doi: 10.3390/antiox9090786. Antioxidants (Basel). 2020. PMID: 32854347 Free PMC article.
The type 5 phosphodiesterase inhibitor tadalafil influences salivary cortisol, testosterone, and dehydroepiandrosterone sulphate responses to maximal exercise in healthy men.
Di Luigi L, Baldari C, Sgrò P, Emerenziani GP, Gallotta MC, Bianchini S, Romanelli F, Pigozzi F, Lenzi A, Guidetti L. Di Luigi L, et al. Among authors: sgro p. J Clin Endocrinol Metab. 2008 Sep;93(9):3510-4. doi: 10.1210/jc.2008-0847. Epub 2008 Jun 17. J Clin Endocrinol Metab. 2008. PMID: 18559908 Clinical Trial.
Combined evaluation of resting IGF1, N-terminal propeptide of type III procollagen and C-terminal cross-linked telopeptide of type I collagen levels might be useful for detecting inappropriate GH administration in female athletes.
Di Luigi L, Rigamonti AE, Agosti F, Mencarelli M, Sgrò P, Marazzi N, Cella SG, Müller EE, Sartorio A. Di Luigi L, et al. Among authors: sgro p. Eur J Endocrinol. 2009 May;160(5):753-8. doi: 10.1530/EJE-08-0884. Epub 2009 Mar 3. Eur J Endocrinol. 2009. PMID: 19258430 Clinical Trial.
Urinary and serum hormones profiles after testosterone enanthate administration in male hypogonadism: concerns on the detection of doping with testosterone in treated hypogonadal athletes.
Di Luigi L, Sgrò P, Romanelli F, Mazzarino M, Donati F, Braganò MC, Bianchini S, Fierro V, Casasco M, Botrè F, Lenzi A. Di Luigi L, et al. Among authors: sgro p. J Endocrinol Invest. 2009 May;32(5):445-53. doi: 10.1007/BF03346484. Epub 2009 Mar 24. J Endocrinol Invest. 2009. PMID: 19461217 Clinical Trial.
79 results